Signal Not Noise: What Mattered in Women’s Health Investing (May 4–May 10)

Women’s health insights through an investor lens. Because headlines fade. Signals shape strategy.

This week’s signals reveal a new threshold: regulatory approvals, funding rounds, and product-market fits that move women's health innovation beyond pitch decks and into real-world delivery.

From the FDA greenlighting the first self-collected cervical cancer screening device, to FemTech markets attracting new capital with global traction, the contours of…